Hirofumi Morihara

J-GLOBAL         Last updated: May 2, 2019 at 21:35
 
Avatar
Name
Hirofumi Morihara
Affiliation
Osaka Medical College
Section
Faculty of Medicine
Research funding number
40802674

Research Areas

 
 

Academic & Professional Experience

 
Apr 2017
 - 
Today
Osaka Medical College
 

Education

 
Apr 2013
 - 
Mar 2017
Osaka University
 
Apr 2007
 - 
Mar 2013
Osaka University of Pharmaceutical Sciences
 

Published Papers

 
Morihara H, Yamamoto T, Oiwa H, Tonegawa K, Tsuchiyama D, Kawakatsu I, Obana M, Maeda M, Mohri T, Obika S, Fujio Y, Nakayama H
Journal of cardiovascular pharmacology and therapeutics   22(3) 273-282   May 2017   [Refereed]
Morihara H, Obana M, Tanaka S, Kawakatsu I, Tsuchiyama D, Mori S, Suizu H, Ishida A, Kimura R, Tsuchimochi I, Maeda M, Yoshimitsu T, Fujio Y, Nakayama H
PloS one   12(12) e0189948   2017   [Refereed]
Matsuo R, Morihara H, Mohri T, Murasawa S, Takewaki K, Nakayama H, Maeda M, Fujio Y
PloS one   9(10) e111097   2014   [Refereed]
Narumoto O, Niikura Y, Ishii S, Morihara H, Okashiro S, Nakahari T, Nakano T, Matsumura H, Shimamoto C, Moriwaki Y, Misawa H, Yamashita N, Nagase T, Kawashima K, Yamashita N
Biochemical and biophysical research communications   438(1) 175-179   Aug 2013   [Refereed]

Conference Activities & Talks

 
Modeling Anderson-Fabry Disease with Human iPSCs Reveals Pathogenic Glycosphingolipid-Induced Cardiac Abnormalities
Hirofumi Morihara, Kiichiro Tomoda, Shigeo Wakabayashi, Michio Asahi
The 92nd Annual Meeting of the Japanese Pharmacological Society   Mar 2019   
Recapitulating fabry disease with human induced pluripotent stem cells and CRISPR interference reveals a signaling axis involved in cardiac phenotypes
Hirofumi Morihara, Kiichiro Tomoda, Shigeo Wakabayashi, Michio Asahi
18th World Congress of Basic and Clinical Pharmacology   Jul 2018